ATM and cancer: This may be reflective of selection on the basis of protein ATM expression, instead of selecting on the basis of ATM inactivating mutations, and/or may reflect the schedule of ATR inhibitor employed, with potentially more continuous schedules being more optimal for ATM-deficient cancers.